Viewing Study NCT03720366


Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2025-12-27 @ 8:23 PM
Study NCT ID: NCT03720366
Status: COMPLETED
Last Update Posted: 2024-02-28
First Post: 2018-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Perpetrator Drug Interactions of Enasidenib in AML Patients
Sponsor: Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module